BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11010146)

  • 1. Want capital? Try a new approach.
    Hessler F
    Health Forum J; 2000; 43(3):suppl 10-1. PubMed ID: 11010146
    [No Abstract]   [Full Text] [Related]  

  • 2. Bonds under scrutiny. IRS audit to look at how the proceeds are used.
    Taylor M
    Mod Healthc; 2005 Jul; 35(30):12. PubMed ID: 16101249
    [No Abstract]   [Full Text] [Related]  

  • 3. Tax-exempt bonds scrutinized. CBO studies use by hospitals, other not-for-profit.
    Taylor M
    Mod Healthc; 2006 Feb; 36(6):4. PubMed ID: 16515077
    [No Abstract]   [Full Text] [Related]  

  • 4. Loading up on debt. Bond issuances on track to break $29 billion record.
    Pallarito K
    Mod Healthc; 1998 Oct; 28(42):44. PubMed ID: 10186327
    [No Abstract]   [Full Text] [Related]  

  • 5. Volume set on high. Tax-exempt bond sales climb 25% in the second quarter.
    Pallarito K
    Mod Healthc; 1997 Jul; 27(28):88, 90. PubMed ID: 10168526
    [No Abstract]   [Full Text] [Related]  

  • 6. Healthy market for tax-exempt bonds.
    Jaklevic MC
    Mod Healthc; 2001 Oct; 31(42):30, 32. PubMed ID: 11682898
    [No Abstract]   [Full Text] [Related]  

  • 7. Revenue Ruling 98-15: dimming the future of all nonprofit joint ventures?
    Griffith GM
    J Health Hosp Law; 1998 Jun; 31(2):71-94. PubMed ID: 10186239
    [No Abstract]   [Full Text] [Related]  

  • 8. When not-for-profits decide to make a buck.
    Findlay S
    Bus Health; 1996 Mar; 14(3):38-9, 41-2, 44-6. PubMed ID: 10156386
    [No Abstract]   [Full Text] [Related]  

  • 9. More hospitals take the tender approach.
    Jaklevic MC
    Mod Healthc; 2000 Dec; 30(51):50. PubMed ID: 11140021
    [No Abstract]   [Full Text] [Related]  

  • 10. Bond sales surge still in forecast.
    Jaklevic MC
    Mod Healthc; 2001 Apr; 31(16):36, 39. PubMed ID: 11330099
    [No Abstract]   [Full Text] [Related]  

  • 11. Capital spigot dripping faster.
    Jaklevic MC
    Mod Healthc; 2002 Feb; 32(5):35-6. PubMed ID: 11859821
    [No Abstract]   [Full Text] [Related]  

  • 12. The price of secrecy. Failure to be forthcoming with financial data could prove costly for bond issuers.
    Pallarito K
    Mod Healthc; 1998 Dec; 28(50):37, 41. PubMed ID: 10187721
    [No Abstract]   [Full Text] [Related]  

  • 13. Handling expected negative news.
    Carpenter D
    Health Forum J; 2001; 44(3):suppl 7. PubMed ID: 11372286
    [No Abstract]   [Full Text] [Related]  

  • 14. A market of contrasts. While stocks dry up, new financing options emerge for assisted living companies.
    Vickery K
    Provider; 1998 Nov; 24(11):28-9, 31, 33-4 passim. PubMed ID: 10338839
    [No Abstract]   [Full Text] [Related]  

  • 15. Bond sales pick up in second quarter.
    Jaklevic MC
    Mod Healthc; 2000 Jul; 30(30):36. PubMed ID: 11184171
    [No Abstract]   [Full Text] [Related]  

  • 16. Bond sales steady in third quarter.
    Jaklevic MC
    Mod Healthc; 2000 Oct; 30(42):40. PubMed ID: 11142205
    [No Abstract]   [Full Text] [Related]  

  • 17. Bonds rebounding after a slow start.
    Jaklevic MC
    Mod Healthc; 2000 May; 30(18):88, 90. PubMed ID: 11067145
    [No Abstract]   [Full Text] [Related]  

  • 18. Growing by leaps and bonds. Not-for-profits sell more despite weak ratings.
    Jaklevic MC
    Mod Healthc; 2004 Jan; 34(2):8-9. PubMed ID: 14959626
    [No Abstract]   [Full Text] [Related]  

  • 19. On a record pace. Tax-exempt bond issues top $17 billion in first half.
    Pallarito K
    Mod Healthc; 1998 Jul; 28(28):52, 54. PubMed ID: 10181364
    [No Abstract]   [Full Text] [Related]  

  • 20. Pricier, less plentiful. For many providers, gone are the days of free-flowing capital.
    Jaklevic MC
    Mod Healthc; 2000 May; 30(21):52-4, 56. PubMed ID: 11067550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.